{"id":"https://openalex.org/W7153287158","doi":"https://doi.org/10.1016/j.medj.2026.101067","title":"Disruptive innovation in breast cancer therapeutic development","display_name":"Disruptive innovation in breast cancer therapeutic development","publication_year":2026,"publication_date":"2026-04-01","ids":{"openalex":"https://openalex.org/W7153287158","doi":"https://doi.org/10.1016/j.medj.2026.101067","pmid":"https://pubmed.ncbi.nlm.nih.gov/41966711"},"language":"en","primary_location":{"id":"doi:10.1016/j.medj.2026.101067","doi":"https://doi.org/10.1016/j.medj.2026.101067","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.medj.2026.101067","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107263261","display_name":"Sridatta V. Teerdhala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sridatta V. Teerdhala","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern, Dallas, TX, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102555866","display_name":"Hannah L. Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah L. Chang","raw_affiliation_strings":["City of Hope Comprehensive Cancer Center, Duarte, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Cancer Center, Duarte, CA, USA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027836515","display_name":"Isaac S. Chan","orcid":"https://orcid.org/0000-0003-2623-3163","observed_orcids":["https://orcid.org/0000-0003-2623-3163"]},"institutions":[{"id":"https://openalex.org/I4390039370","display_name":"Harold C. Simmons Comprehensive Cancer Center","ror":"https://ror.org/03cbz4r60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039370","https://openalex.org/I867280407"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Isaac S. Chan","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern, Dallas, TX, USA; Department of Molecular Biology, University of Texas Southwestern, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern, Dallas, TX, USA. Electronic address: isaac.chan@utsouthwestern.edu"],"raw_orcid":"https://orcid.org/0000-0003-2623-3163","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern, Dallas, TX, USA; Department of Molecular Biology, University of Texas Southwestern, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern, Dallas, TX, USA. Electronic address: isaac.chan@utsouthwestern.edu","institution_ids":["https://openalex.org/I4390039370","https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5027836515"],"corresponding_institution_ids":["https://openalex.org/I4390039370","https://openalex.org/I867280407"],"apc_list":{"value":9350,"currency":"USD","value_usd":9350},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20879007,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"4","first_page":"101067","last_page":"101067"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.23430000245571136,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/disruptive-innovation","display_name":"disruptive innovation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/treatment-development","display_name":"treatment development","score":0.6819999814033508},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7599999904632568},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cell-and-gene-therapy","display_name":"cell and gene therapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/business-impact","display_name":"business impact","score":0.46000000834465027},{"id":"https://openalex.org/keywords/clinical-impact","display_name":"clinical impact","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2777785971","wikidata":"https://www.wikidata.org/wiki/Q1192297","display_name":"Disruptive innovation","level":2,"score":0.7231000065803528},{"id":"https://openalex.org/C155911762","wikidata":"https://www.wikidata.org/wiki/Q422321","display_name":"Blueprint","level":2,"score":0.6866999864578247},{"id":"https://openalex.org/C2984734790","wikidata":"https://www.wikidata.org/wiki/Q1192297","display_name":"Disruptive technology","level":2,"score":0.6424999833106995},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5684000253677368},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5583000183105469},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33309999108314514},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.30379998683929443},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.2928999960422516},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25380000472068787},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2522999942302704}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.medj.2026.101067","doi":"https://doi.org/10.1016/j.medj.2026.101067","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.medj.2026.101067","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},{"id":"pmid:41966711","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41966711","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000898154","display_name":"UT Southwestern Medical Center Simmons Comprehensive Cancer Center","funder_award_id":"P30CA142543","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307408","display_name":"Robert J. and Claire Pasarow Foundation","ror":"https://ror.org/053hskf20"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W2734670400","https://openalex.org/W3041158987","https://openalex.org/W3192089553","https://openalex.org/W4311029059","https://openalex.org/W4362657052","https://openalex.org/W4377087871","https://openalex.org/W4389553831","https://openalex.org/W4402558548","https://openalex.org/W4409148758"],"related_works":["https://openalex.org/W2139744320","https://openalex.org/W4246086746","https://openalex.org/W4312131127","https://openalex.org/W7131641892","https://openalex.org/W3024836555","https://openalex.org/W3208416553","https://openalex.org/W1985686668","https://openalex.org/W2085170149","https://openalex.org/W760266963","https://openalex.org/W4291298122"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-04-11T00:00:00"}